SightfileU.S. market data from official filings

Companies › CNTA

CENTESSA PHARMACEUTICALS PLC (CNTA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001847903 · EDGAR filings · Updated 2026-07-08

CENTESSA PHARMACEUTICALS PLC (CNTA) has reported institutional ownership of 96.2%, with 160 institutional managers holding positions valued at $5.90B per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04).

Institutional ownership
96.2%
Institutional managers
160
Reported 13F value
$5.90B
Insider activity
97 trans.
−$18.2M net selling
Data flags
2 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CENTESSA PHARMACEUTICALS PLC has 160 institutional holders and institutional ownership of 96.2%.

Insider activity

Insiders reported 97 transactions (2 buys, 46 sells) across 10 reporting insiders, with a net reported value of −$18.2M.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-06-24 (recurring since 2026-06-24) — source filing. The authoritative details are those stated in the filing itself.
Active triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04), most recently filed 2022-12-23 (recurring since 2022-02-14) — source filing. The authoritative details are those stated in the filing itself.

Related companies

GLAUKOS CORP (GKOS) · ALKERMES PLC (ALKS) · CG ONCOLOGY INC (CGON) · XENON PHARMACEUTICALS INC (XENE) · TELEFLEX INCORPORATED (TFX) · CELCUITY INC (CELC)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-08.